Discover 3,049 paid clinical trials in Thousand Oaks, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,049
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
for
Refractory Rheumatoid Arthritis (RA),
Location: Los Angeles CA, Los Alamitos CA, Covina CA,
Sponsor: Artiva Biotherapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06991114
Phase 2, Recruiting
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Los Angeles CA, Los Alamitos CA, Irvine CA, La Jolla CA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06973187
Phase 3, Recruiting
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
for
Castration Levels of Testosterone,
Location: Los Angeles CA, Long Beach CA, Duarte CA,
Sponsor: SWOG Cancer Research Network
Sex: Male
Age: 18+
Code: NCT03678025
Phase 3, Recruiting
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
for
Colorectal Neoplasms
Location: Duarte CA, La Jolla CA, Weston FL, Philadelphia PA,
Sponsor: Surgimab
Sex: All
Age: 18+
Code: NCT03659448
Phase 3, Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Los Angeles CA, Burbank CA, Duarte CA, Santa Barbara CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213804
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
for
Mantle Cell Lymphoma
Location: Los Angeles CA, Beverly Hills CA, Salt Lake City UT,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 60+
Code: NCT05976763
Phase 3, Recruiting
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Los Angeles CA, Fullerton CA, San Francisco CA,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06203210
Phase 3, Recruiting
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Location: Los Angeles CA, Edmonton, Winnipeg, Madison WI, Toronto,
Sponsor: Apollomics Inc.
Sex: All
Age: 18+
Code: NCT03175224
Phase 2, Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
for
Advanced Non-Small Cell Lung Cancer,
Location: Long Beach CA, Cerritos CA, Los Alamitos CA, Anaheim CA,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT04613596
Phase 2, Phase 3, Recruiting
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
for
Advanced Malignant Neoplasm, Breast Cancer, Ovarian Cancer,
Location: Los Angeles CA, Houston TX, Nashville TN, Baltimore MD
Sponsor: AtlasMedx, Incorporated
Sex: All
Age: 18+
Code: NCT04503265
Phase 1, Phase 2, Recruiting
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults And Adolescent Participants Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
for
Central Line Associated Blood Stream Infections (CLABSI)
Location: Los Angeles CA, Omaha NE, Sugarland TX, Rochester MN,
Sponsor: CorMedix Therapeutics
Sex: All
Age: 12+
Code: NCT06822426
Phase 3, Recruiting
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
for
Urinary Bladder Neoplasms, Neoplasm Metastasis,
Location: Los Angeles CA, Duarte CA, Orange CA, Stanford CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05614739
Phase 1, Recruiting
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
for
Locally Advanced Lung Non-Small Cell Carcinoma,
Location: Los Angeles CA, Bakersfield CA, Modesto CA, Kingman AZ,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT05624996
Phase 3, Recruiting
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
for
Heart Failure, Heart Failure With Reduced Ejection Fraction
Location: Los Angeles CA, Beverly Hills CA, Torrance CA,
Sponsor: Cytokinetics
Sex: All
Age: 18 - 70+
Code: NCT06736574
Phase 3, Recruiting
Adapting Lifestyle Offloading for DFUs
for
Diabetic Foot Ulcer, Diabetic Foot
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 21+
Code: NCT06278935
Recruiting
The Myelin Disorders Biorepository Project
for
Leukodystrophy, White Matter Disease, Leukoencephalopathies,
Location: Los Angeles CA, Orange CA, San Diego CA, Palo Alto CA,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0+
Code: NCT03047369
Recruiting
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
for
Aortic Stenosis, Calcific, Aortic Valve Stenosis
Location: Los Angeles CA, Santa Barbara CA, Rancho Mirage CA,
Sponsor: Edwards Lifesciences
Sex: All
Age: 65+
Code: NCT04889872
Recruiting
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
for
Melanoma, Cutaneous Malignant
Location: Los Angeles CA, Duarte CA, La Jolla CA, Stanford CA,
Sponsor: Immatics US, Inc.
Sex: All
Age: 18+
Code: NCT06743126
Phase 3, Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Los Angeles CA, Beverly Hills CA, Torrance CA,